Trial intelligence / Profile preview

Extended Dalteparin VTE Prophylaxis in Thoracic Surgery

NCT02334007Phase 2Completed

Sponsor
McMaster University
Start
Sep 2015
Primary completion
Sep 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of dalteparin in venous thromboembolism (VTE), sponsored by McMaster University. Started Sep 2015; status: completed.

02

Drugs

dalteparin
03

Conditions

venous thromboembolism (VTE)

Beyond the preview

Go deeper on NCT02334007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02334007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call